Delaware
(State
or Other Jurisdiction
of
Incorporation)
|
000-30929
(Commission
File Number)
|
13-4087132
(IRS
Employer Identification No.)
|
£
|
Written
communications pursuant to Rule 425 under the Securities
Act.
|
£
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act.
|
£
|
Pre-commencement
communications pursuant to Rule 14d-2b under the Exchange
Act.
|
£
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act.
|
Exhibit
Number
|
Description | |
99.1 | Press Release dated September 20, 2006. |
Keryx
Biopharmaceuticals, Inc.
(Registrant)
|
||
|
|
|
Date: September 19, 2006 | By: | /s/ Ronald C. Renaud, Jr. |
Ronald C. Renaud, Jr. |
||
Senior
Vice President,
Chief
Financial Officer,
Secretary
and
Treasurer
|
Exhibit
Number
|
Description | |
99.1 | Press Release dated September 20, 2006. |